NCT05578573

Brief Summary

Comparison of success rate and complication between conventional angiocatheter versus new anchoring device (KARAHOC) used for paracentesis in cirrhotic patients with ascites.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 16, 2022

Completed
1 day until next milestone

Study Start

First participant enrolled

January 17, 2022

Completed
9 months until next milestone

First Posted

Study publicly available on registry

October 13, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

October 13, 2022

Status Verified

October 1, 2022

Enrollment Period

12 months

First QC Date

January 16, 2022

Last Update Submit

October 10, 2022

Conditions

Keywords

paracentesiscirrhosisascites

Outcome Measures

Primary Outcomes (1)

  • Comparison of success rate between conventional angiocatheter versus KARAHOC device used for paracentesis

    The criterion for successful paracentesis is defined as drainage of 3L or more at an initial attempt.

    through study completion, an average of 1 year

Secondary Outcomes (4)

  • comparison of complication rate

    through study completion, an average of 1 year

  • operator satisfaction for each procedure

    through study completion, an average of 1 year

  • patient satisfaction for each procedure

    through study completion, an average of 1 year

  • Number of Participants with repeated paracentesis

    through study completion, an average of 1 year

Study Arms (2)

KARAHOC group

EXPERIMENTAL

A group of patients in which paracentesis will be performed using a KARAHOC device.

Device: KARAHOC device

conventional group

ACTIVE COMPARATOR

A group of patients in which paracentesis will be performed using an angiocatheter.

Device: Angiocatheter

Interventions

After leaving a mark on the part where the puncture is to be performed using a pen, sterilization dressing are performed, local anesthesia is performed aseptic then ascites paracentesis by KARAHOC device.

KARAHOC group

After leaving a mark on the part where the puncture is to be performed using a pen, sterilization dressing are performed, local anesthesia is performed aseptic then ascites paracentesis by angiocatheter

conventional group

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult over the age of 19
  • Patients with pathological or clinical diagnosis of liver cirrhosis
  • Patients with Grade 2 or higher grade of ascites as a complication due to portal hypertension
  • Patients requiring periodic paracentesis
  • Patients consent to this study

You may not qualify if:

  • Patients with ascites due to peritoneal metastasis due to malignant tumor
  • Patients with high bleeding risk (PT INR\>3, PLT\<30,000/mm3) difficult to perform ascites puncture
  • Patients with hepatic encephalopathy or hepatorenal syndrome(HRS)
  • Patients with severe cardiovascular disease, lung disease, or DIC
  • Patients refusing paracentesis
  • Patients who can control ascites using diuretics
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Soon Chun Hyang University Bucheon Hospital

Bucheon-si, Gyeonggi-do, 14584, South Korea

Location

Related Publications (6)

  • Iwakiri Y. Pathophysiology of portal hypertension. Clin Liver Dis. 2014 May;18(2):281-91. doi: 10.1016/j.cld.2013.12.001. Epub 2014 Feb 25.

    PMID: 24679494BACKGROUND
  • Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis. Gut. 2006 Oct;55 Suppl 6(Suppl 6):vi1-12. doi: 10.1136/gut.2006.099580. No abstract available.

    PMID: 16966752BACKGROUND
  • Gentilini P, Casini-Raggi V, Di Fiore G, Romanelli RG, Buzzelli G, Pinzani M, La Villa G, Laffi G. Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. J Hepatol. 1999 Apr;30(4):639-45. doi: 10.1016/s0168-8278(99)80194-9.

    PMID: 10207805BACKGROUND
  • Gines P, Arroyo V, Quintero E, Planas R, Bory F, Cabrera J, Rimola A, Viver J, Camps J, Jimenez W, et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology. 1987 Aug;93(2):234-41. doi: 10.1016/0016-5085(87)91007-9.

    PMID: 3297907BACKGROUND
  • Quintero E, Gines P, Arroyo V, Rimola A, Bory F, Planas R, Viver J, Cabrera J, Rodes J. Paracentesis versus diuretics in the treatment of cirrhotics with tense ascites. Lancet. 1985 Mar 16;1(8429):611-2. doi: 10.1016/s0140-6736(85)92147-6.

    PMID: 2857949BACKGROUND
  • Salerno F, Badalamenti S, Incerti P, Tempini S, Restelli B, Bruno S, Bellati G, Roffi L. Repeated paracentesis and i.v. albumin infusion to treat 'tense' ascites in cirrhotic patients. A safe alternative therapy. J Hepatol. 1987 Aug;5(1):102-8. doi: 10.1016/s0168-8278(87)80067-3.

    PMID: 3655306BACKGROUND

MeSH Terms

Conditions

FibrosisAscites

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Sang gyune Kim, PhD

    Soonchunhyang University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: multi-center, prospective, interventional study
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 16, 2022

First Posted

October 13, 2022

Study Start

January 17, 2022

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

October 13, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

There is not a plan to make IPD available.

Locations